Stereotaxis, Inc. SEC filings STXS
Stereotaxis, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Jan 4, 2011. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 3, 2026 | — |
| DEF 14A | Proxy statement | Apr 3, 2026 | Apr 3, 2026 |
| DEFA14A | Additional proxy material | Apr 4, 2025 | — |
| DEF 14A | Proxy statement | Apr 4, 2025 | Apr 4, 2025 |
| DEFA14A | Additional proxy material | Apr 8, 2024 | — |
| DEFA14A | Additional proxy material | Apr 4, 2024 | — |
| DEF 14A | Proxy statement | Apr 4, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 5, 2023 | — |
| DEF 14A | Proxy statement | Apr 5, 2023 | Apr 5, 2023 |
| DEFA14A | Additional proxy material | Apr 8, 2022 | — |
| DEF 14A | Proxy statement | Apr 8, 2022 | Apr 8, 2022 |
| DEFA14A | Additional proxy material | May 10, 2021 | — |
| DEFA14A | Additional proxy material | Apr 9, 2021 | — |
| DEF 14A | Proxy statement | Apr 9, 2021 | Apr 9, 2021 |
| DEFA14A | Additional proxy material | Apr 9, 2020 | — |
| DEF 14A | Proxy statement | Apr 9, 2020 | Apr 9, 2020 |
| DEFA14A | Additional proxy material | Apr 10, 2019 | — |
| DEF 14A | Proxy statement | Apr 10, 2019 | Apr 9, 2019 |
| PRE 14A | Preliminary proxy statement | Mar 28, 2019 | Mar 27, 2019 |
| DEFA14A | Additional proxy material | Apr 12, 2018 | — |
| DEF 14A | Proxy statement | Apr 12, 2018 | May 22, 2018 |
| PRE 14A | Preliminary proxy statement | Mar 29, 2018 | May 22, 2018 |
| DEFA14A | Additional proxy material | Apr 13, 2017 | — |
| DEF 14A | Proxy statement | Apr 13, 2017 | May 23, 2017 |
| DEFA14A | Additional proxy material | Apr 14, 2016 | — |
| DEF 14A | Proxy statement | Apr 14, 2016 | May 24, 2016 |
| DEFA14A | Additional proxy material | Apr 17, 2015 | — |
| DEF 14A | Proxy statement | Apr 17, 2015 | Jun 2, 2015 |
| DEF 14A | Proxy statement | Apr 28, 2014 | Jun 10, 2014 |
| DEF 14A | Proxy statement | Apr 26, 2013 | Jun 5, 2013 |
| DEF 14A | Proxy statement | Jul 20, 2012 | Aug 22, 2012 |
| DEF 14A | Proxy statement | Jun 8, 2012 | Jul 10, 2012 |
| PRE 14A | Preliminary proxy statement | May 25, 2012 | May 25, 2012 |
| DEF 14A | Proxy statement | Apr 15, 2011 | May 25, 2011 |
Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- STXS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- St.Louis, MO
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1289340
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.